Gout, a type of arthritis, is not only incurable but affects an estimated 8 million people in America. There’s a drug on the market right now called febuxostat (brand name: Uloric) that has been used to treat hyperuricemia in patients with gout, but one nonprofit is urging the U.S. Food and Drug Administration to immediately remove it from the market for very compelling reasons.

Show note links:

Learn more about gout, including signs, symptoms, causes , how it’s diagnosed & more by checking out these CDC Arthritis Basics.

What is hyperuricemia? Learn more here.

To read the full 23-page petition to the FDA from Public Citizen, read here.

Gout is more common in men vs. women and is more prevalent in African Americans vs. white patient populations. Read more about the gender and racial disparities here.

Got side effects? Report them to the FDA today. Call 1-800-332-1088 or report online at www.fda.gov/medwatch